XODUS MEDICAL v. Mullen: Surgical Pad Patent Case Ends in Dismissal

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

Case Overview

After nearly five years of litigation spanning 1,770 days, XODUS MEDICAL, Inc. v. Mark Mullen concluded not with a courtroom verdict but with a stipulated dismissal without prejudice — a resolution that raises as many strategic questions as it answers. Filed on March 12, 2021, in the U.S. District Court for South Carolina under Case No. 7:21-cv-00727, the case centered on three U.S. patents covering surgical positioning and patient protection technology, with XODUS MEDICAL alleging infringement tied to its proprietary **SurgyPad** product line.

For patent attorneys tracking medical device IP litigation, IP professionals monitoring surgical equipment patent trends, and R&D teams assessing freedom-to-operate risk in the operating room technology space, this case offers a textbook example of how prolonged district-court proceedings can culminate in a negotiated exit — and what that outcome signals about litigation leverage, portfolio strength, and commercial risk calculus in the medical device sector.

The Parties

⚖️ Plaintiff

A medical device company focused on surgical patient safety products, including warming and positioning solutions used in operating room environments. Holds a notable patent portfolio directed at surgical pad technology.

🛡️ Defendant

Named as an individual defendant in this infringement action. The specific commercial or inventive role attributed to Mullen in relation to the accused products was not publicly elaborated.

Patents at Issue

This case involved three U.S. patents covering surgical positioning and patient protection technology. Together, these patents represent a coordinated IP portfolio protecting overlapping aspects of surgical pad design and functionality — a common multi-patent assertion strategy intended to maximize claim coverage and litigation leverage.

🔍

Designing a similar medical device product?

Check if your surgical pad design might infringe these or related patents before launch.

Run FTO Check →

The Verdict & Legal Analysis

Outcome

The case was resolved by stipulated dismissal without prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii). Per the parties’ stipulation, each side agreed to bear its own attorneys’ fees and costs. No damages award, injunctive relief, or consent judgment was entered.

Key Legal Issues

The case was brought as a straightforward patent infringement action. Because the matter resolved by mutual stipulation rather than judicial ruling, no formal claim construction order, invalidity finding, or infringement determination was issued by the court. As a result, the three patents-in-suit — US8511314B2, US8464720B1, and US9161876B2 — emerge from this litigation with their validity formally unchallenged by any court ruling.

The absence of a damages figure or injunctive outcome is consistent with a privately negotiated resolution, whether that took the form of a licensing agreement, a covenant not to sue, a design-around arrangement, or a purely commercial settlement whose terms were not made part of the public record.

⚠️

Freedom to Operate (FTO) Analysis

This case highlights critical IP risks in medical device design, especially surgical pads. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications from this litigation.

  • View all related patents in this medical device technology space
  • See which companies are most active in surgical pad patents
  • Understand claim construction patterns
📊 View Patent Landscape
⚠️
High Risk Area

Surgical pads with specific positioning features

📋
3 Patents at Issue

In surgical pad technology

Design-Around Options

Available for many aspects of design

✅ Key Takeaways

For Patent Attorneys

Multi-patent assertion from related application families (US13/773290, US13/737552, US13/957778) strengthens infringement claims and complicates invalidity defenses.

Search related case law →

A Rule 41(a)(1)(A)(ii) without-prejudice dismissal preserves enforcement rights — distinguish from with-prejudice outcomes when advising clients on settlement structures.

Explore precedents →

No claim construction issued — the three XODUS MEDICAL patents carry forward without adverse judicial interpretation, preserving portfolio value.

Analyze claim scope →
🔒
Unlock R&D Team Recommendations
Get actionable medical device IP strategy steps for product teams, including FTO timing guidance and competitive analysis.
FTO Timing Guidance Design-Around Strategies Competitive IP Benchmarking
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified
⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.